Search details
1.
Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(12): e29999, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36215217
2.
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort.
Acta Haematol
; 145(6): 592-602, 2022.
Article
in English
| MEDLINE | ID: mdl-35790143
3.
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 843-854, 2021 03 02.
Article
in English
| MEDLINE | ID: mdl-33651091
4.
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.
Blood Adv
; 6(3): 1004-1014, 2022 02 08.
Article
in English
| MEDLINE | ID: mdl-34979020
5.
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.
Leuk Lymphoma
; 63(9): 2063-2073, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35503708
6.
Clobazam in the treatment of Lennox-Gastaut syndrome.
Epilepsia
; 50(5): 1158-66, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19170737
7.
Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
Drug Saf
; 42(5): 587-601, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30565020
8.
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.
Blood Adv
; 2(13): 1522-1531, 2018 07 10.
Article
in English
| MEDLINE | ID: mdl-29954814
9.
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL.
Leukemia
; 37(1): 222-225, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36482128
Results
1 -
9
de 9
1
Next >
>>